Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Cognitive Impairment in Multiple Sclerosis.
Modulation of the Innate Immune Response by Human Neural Precursors Prevails Over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model Of Pelizaeus-Merzbacher Disease.
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse.
Regulatory effects of fisetin on microglial activation.
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.

Pages